AllerGene AI Therapeutics is pioneering the first in vivo mRNA-LNP CAR-T platform designed to eliminate disease-driving mast cells, safely resetting the immune system without permanent alteration. Mast cells are central…
Biotechnology software for clinics
5 companies in the directory build clinic and practice-management software under Biotechnology. They cluster around Biotechnology, Immuno-oncology and Immunotherapy. AllerGene AI Therapeutics, Genix Therapeutics and NanoKar Therapeutics are among them. 2 have disclosed funding. Founding years run from 2005 to 2025.
5 productsGenix Therapeutics
Genix Therapeutics is a niche, R&D stage, virtual pharmaceutical company focused on the identification and development of challenging generic injectable products.
Genix Therapeutics is an R&D stage virtual pharmaceutical company focused on identifying and developing complex generic injectable products. The company works with partners including suppliers, manufacturers, labs, and…
NanoKar Therapeutics
ITAM-Optimized Cell Therapy Platform
NanoKar Therapeutics discovered that chimeric antigen receptors function as mechanosensors, and developed a platform to engineer them. Our patent-pending ITAM optimization technology tunes the intracellular signaling of…
QLSF Biotherapeutics, Inc.
An innovative immuno-oncology startup focused on tumor biology driven therapeutic strategies in oncology.
QLSF Biotherapeutics is an immuno-oncology company in South San Francisco developing antibody-based therapeutics for cancer treatment. The company designs candidates targeting adaptive and innate immunity across a diver…
Sift Biosciences
Proprietary AI-driven discovery platform for T-cell modulating therapies
Sift Biosciences is a biotechnology company developing an AI-driven platform to discover T-cell modulators derived from bacteria and viruses for treating cancer and autoimmune diseases. The platform combines artificial…


